205 related articles for article (PubMed ID: 19699304)
1. Disruption of Rab11 activity in a knock-in mouse model of Huntington's disease.
Li X; Sapp E; Chase K; Comer-Tierney LA; Masso N; Alexander J; Reeves P; Kegel KB; Valencia A; Esteves M; Aronin N; Difiglia M
Neurobiol Dis; 2009 Nov; 36(2):374-83. PubMed ID: 19699304
[TBL] [Abstract][Full Text] [Related]
2. Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice.
McClory H; Williams D; Sapp E; Gatune LW; Wang P; DiFiglia M; Li X
Acta Neuropathol Commun; 2014 Dec; 2():179. PubMed ID: 25526803
[TBL] [Abstract][Full Text] [Related]
3. Deficient Rab11 activity underlies glucose hypometabolism in primary neurons of Huntington's disease mice.
Li X; Valencia A; McClory H; Sapp E; Kegel KB; Difiglia M
Biochem Biophys Res Commun; 2012 May; 421(4):727-30. PubMed ID: 22542623
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.
Li X; Valencia A; Sapp E; Masso N; Alexander J; Reeves P; Kegel KB; Aronin N; Difiglia M
J Neurosci; 2010 Mar; 30(13):4552-61. PubMed ID: 20357106
[TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity.
Li X; Standley C; Sapp E; Valencia A; Qin ZH; Kegel KB; Yoder J; Comer-Tierney LA; Esteves M; Chase K; Alexander J; Masso N; Sobin L; Bellve K; Tuft R; Lifshitz L; Fogarty K; Aronin N; DiFiglia M
Mol Cell Biol; 2009 Nov; 29(22):6106-16. PubMed ID: 19752198
[TBL] [Abstract][Full Text] [Related]
6. Impaired XK recycling for importing manganese underlies striatal vulnerability in Huntington's disease.
Chhetri G; Ke Y; Wang P; Usman M; Li Y; Sapp E; Wang J; Ghosh A; Islam MA; Wang X; Boudi A; DiFiglia M; Li X
J Cell Biol; 2022 Oct; 221(10):. PubMed ID: 36099524
[TBL] [Abstract][Full Text] [Related]
7. Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease.
Richards P; Didszun C; Campesan S; Simpson A; Horley B; Young KW; Glynn P; Cain K; Kyriacou CP; Giorgini F; Nicotera P
Cell Death Differ; 2011 Feb; 18(2):191-200. PubMed ID: 21217767
[TBL] [Abstract][Full Text] [Related]
8. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.
Valencia A; Sapp E; Kimm JS; McClory H; Reeves PB; Alexander J; Ansong KA; Masso N; Frosch MP; Kegel KB; Li X; DiFiglia M
Hum Mol Genet; 2013 Mar; 22(6):1112-31. PubMed ID: 23223017
[TBL] [Abstract][Full Text] [Related]
9. Multiple phenotypes in Huntington disease mouse neural stem cells.
Ritch JJ; Valencia A; Alexander J; Sapp E; Gatune L; Sangrey GR; Sinha S; Scherber CM; Zeitlin S; Sadri-Vakili G; Irimia D; Difiglia M; Kegel KB
Mol Cell Neurosci; 2012 May; 50(1):70-81. PubMed ID: 22508027
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
Akbergenova Y; Littleton JT
J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
[TBL] [Abstract][Full Text] [Related]
11. Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease.
Steinert JR; Campesan S; Richards P; Kyriacou CP; Forsythe ID; Giorgini F
Hum Mol Genet; 2012 Jul; 21(13):2912-22. PubMed ID: 22466800
[TBL] [Abstract][Full Text] [Related]
12. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
13. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
14. Striatal synaptosomes from Hdh140Q/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation.
Valencia A; Sapp E; Kimm JS; McClory H; Ansong KA; Yohrling G; Kwak S; Kegel KB; Green KM; Shaffer SA; Aronin N; DiFiglia M
J Huntingtons Dis; 2013; 2(4):459-75. PubMed ID: 24696705
[TBL] [Abstract][Full Text] [Related]
15. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
[TBL] [Abstract][Full Text] [Related]
16. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
17. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
[TBL] [Abstract][Full Text] [Related]
18. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
[TBL] [Abstract][Full Text] [Related]
19. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
20. PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically.
Dickey AS; Pineda VV; Tsunemi T; Liu PP; Miranda HC; Gilmore-Hall SK; Lomas N; Sampat KR; Buttgereit A; Torres MJ; Flores AL; Arreola M; Arbez N; Akimov SS; Gaasterland T; Lazarowski ER; Ross CA; Yeo GW; Sopher BL; Magnuson GK; Pinkerton AB; Masliah E; La Spada AR
Nat Med; 2016 Jan; 22(1):37-45. PubMed ID: 26642438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
